Source | us.nlm.vsac#0.11.0:null (v4.0.1) |
resourceType | ValueSet |
id | 2.16.840.1.113883.3.666.5.2345 |
canonical | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.2345 |
version | 20160331 |
status | active |
publisher | Lantana EH Steward |
name | ImmunodeficientConditionsI9 |
title | Immunodeficient Conditions I9 |
date | 2016-03-31T01:00:12-04:00 |
experimental | false |
Usages |
|
This value set contains 35 concepts
Code | System | Display |
042 | http://hl7.org/fhir/sid/icd-9-cm | Human immunodeficiency virus [HIV] disease |
079.53 | http://hl7.org/fhir/sid/icd-9-cm | Human immunodeficiency virus, type 2 [HIV-2] |
204.10 | http://hl7.org/fhir/sid/icd-9-cm | Chronic lymphoid leukemia, without mention of having achieved remission |
204.11 | http://hl7.org/fhir/sid/icd-9-cm | Chronic lymphoid leukemia, in remission |
204.12 | http://hl7.org/fhir/sid/icd-9-cm | Chronic lymphoid leukemia, in relapse |
279.00 | http://hl7.org/fhir/sid/icd-9-cm | Hypogammaglobulinemia, unspecified |
279.01 | http://hl7.org/fhir/sid/icd-9-cm | Selective IgA immunodeficiency |
279.02 | http://hl7.org/fhir/sid/icd-9-cm | Selective IgM immunodeficiency |
279.05 | http://hl7.org/fhir/sid/icd-9-cm | Immunodeficiency with increased IgM |
279.06 | http://hl7.org/fhir/sid/icd-9-cm | Common variable immunodeficiency |
279.09 | http://hl7.org/fhir/sid/icd-9-cm | Other deficiency of humoral immunity |
279.10 | http://hl7.org/fhir/sid/icd-9-cm | Immunodeficiency with predominant T-cell defect, unspecified |
279.11 | http://hl7.org/fhir/sid/icd-9-cm | Digeorge's syndrome |
279.12 | http://hl7.org/fhir/sid/icd-9-cm | Wiskott-aldrich syndrome |
279.13 | http://hl7.org/fhir/sid/icd-9-cm | Nezelof's syndrome |
279.19 | http://hl7.org/fhir/sid/icd-9-cm | Other deficiency of cell-mediated immunity |
279.2 | http://hl7.org/fhir/sid/icd-9-cm | Combined immunity deficiency |
279.3 | http://hl7.org/fhir/sid/icd-9-cm | Unspecified immunity deficiency |
795.71 | http://hl7.org/fhir/sid/icd-9-cm | Nonspecific serologic evidence of human immunodeficiency virus [HIV] |
V01.79 | http://hl7.org/fhir/sid/icd-9-cm | Contact with or exposure to other viral diseases |
V08 | http://hl7.org/fhir/sid/icd-9-cm | Asymptomatic human immunodeficiency virus [HIV] infection status |
V42.0 | http://hl7.org/fhir/sid/icd-9-cm | Kidney replaced by transplant |
V42.1 | http://hl7.org/fhir/sid/icd-9-cm | Heart replaced by transplant |
V42.2 | http://hl7.org/fhir/sid/icd-9-cm | Heart valve replaced by transplant |
V42.3 | http://hl7.org/fhir/sid/icd-9-cm | Skin replaced by transplant |
V42.4 | http://hl7.org/fhir/sid/icd-9-cm | Bone replaced by transplant |
V42.5 | http://hl7.org/fhir/sid/icd-9-cm | Cornea replaced by transplant |
V42.6 | http://hl7.org/fhir/sid/icd-9-cm | Lung replaced by transplant |
V42.7 | http://hl7.org/fhir/sid/icd-9-cm | Liver replaced by transplant |
V42.81 | http://hl7.org/fhir/sid/icd-9-cm | Bone marrow replaced by transplant |
V42.82 | http://hl7.org/fhir/sid/icd-9-cm | Peripheral stem cells replaced by transplant |
V42.83 | http://hl7.org/fhir/sid/icd-9-cm | Pancreas replaced by transplant |
V42.84 | http://hl7.org/fhir/sid/icd-9-cm | Organ or tissue replaced by transplant, intestines |
V42.89 | http://hl7.org/fhir/sid/icd-9-cm | Other specified organ or tissue replaced by transplant |
V42.9 | http://hl7.org/fhir/sid/icd-9-cm | Unspecified organ or tissue replaced by transplant |
Produced 08 Sep 2023